Catalio Capital Management, LPFirm match from fund name (lower confidence)
Catalio Access Fund IX, LLC
Open, writing first checks
Open: first sale Mar 2026, per Form D (fund age approximates vintage)
- Vintage
- 2026
- Fund size
- $17.34M (Form D)
- Stages
- Not stated
- Sectors
- Biotech, Medical devices, Healthtech, Digital health, Life sciences and research tools
- Regions
- Not stated
01 · Thesis
Catalio invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its portfolio spans drugs, devices, diagnostics and AI-enabled companies, sourced partly through serial scientist-entrepreneur venture partners.Inferred from the firm's website
02 · Initial check
$173K to $289K (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- George C. Petrocheilos, Co-Founder & Managing Partner
- R. Jacob Vogelstein, Ph.D., Co-Founder & Managing Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideCatalio invests in innovative healthcare companies at all stages and sizes, across the capital structure.
At Catalio, we invest in innovative healthcare companies at all stages and sizes, and throughout the capital structure.
https://cataliocapital.com/
06 · Sources
Last verified: Oct 28, 2026